Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 653-666

  Di Girolamo, Nick ^a   Lloyd, Andrew ^a   McCluskey, Peter ^a   Filipic, Marijan ^b   Wakefield, Denis ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY EYE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL INFILTRATION; CLINICAL ARTICLE; ENZYME ACTIVITY; EYE INFLAMMATION; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCLERITIS;

ADULT; AGED; BLOTTING, WESTERN; COLLAGENASES; FEMALE; FIBROBLASTS; GLYCOPROTEINS; HUMANS; INTERLEUKIN-1; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; RNA, MESSENGER; SCLERA; SCLERITIS; TISSUE DISTRIBUTION; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031026493     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Tuft SJ, Watson PG: Progression of scleral disease. Ophthalmology 1991, 98:467-471
2. de la Maza MS, Foster CS, Jabbur NS: Scleritis associated with systemic vasculitic diseases. Ophthalmology 1995, 102:687-692
3. Rao NA, Marak GE, Hidayat AA: Necrotizing scleritis: a clinico-pathologic study of 41 cases. Ophthalmology 1985, 92:1542-1554
4. McCluskey P, Wakefield D: Episcleritis and scleritis. Ocular Infection and Immunity. Edited by GN Holland, K Wilhelmus, J Pepose. New York, Mosby, 1996, pp 642-662
5. Conca W, Kaplan PB, Krane SM: Increases in levels of procollagenase messenger RNA in cultured fibroblasts induced by human recombinant interleukin 1β or serum follow c-jun expression are dependent on new protein synthesis. J Clin Invest 1989, 83:1753-1757
6. Quinones S, Saus J, Otani Y, Harris ED, Kurkinen M Jr: Transcriptional regulation of human stromelysin. J Biol Chem 1989, 264:8339-8344
7. Firestein GS: Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis, Curr Opin Rheumatol 1992, 4:348-354
8. Matrisian LM: The matrix-degrading metalloproteinases. Bioassays 1992, 14:455-463
9. Lohmander LS, Hoerrner LA, Lark MW: Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis, Arthritis Rheum 1993, 36:181-189
10. Firestein GS, Paine MM: Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. Am J Pathol 1992, 140:1309-1314
11. Khokha R, Denhardt DT: Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metastasis 1989, 9:391-405
12. McDonnell S, Matrisian LM: Stromelysin in tumor progression and metastases. Cancer Metastasis Rev 1990, 9:305-319
13. Ray JM, Stetler-Stevenson WG: The role of matrix metalloproteinases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994, 7:2062-2072
14. Murphy G, Cocklett MI, Ward RV, Docherty AJ: Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycans. Biochem J 1991, 277:277-279
15. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE: Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996, 97:761-768
16. Takino T, Sato H, Shinagawa A, Seiki M: Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 1995, 270:23013-23020
17. Mauviel A: Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 1993, 53:288-295
18. Agarwal C, Hembree JR. Rorke EA, Eckert RL: Transforming growth factor β1 regulation of metalloproteinase production in cultured human cervical epithelial cells, Cancer Res 1994, 54:943-949
19. Matrisian LM: The matrix-degrading metalloproteinases. Trends Genet 1990, 6:121-125
20. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling, FASEB J 1991, 5:2145-2154
21. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M: Phorbol ester-inducible genes contain a common cis element recognised by a TPA-modulated trans-acting factor. Cell 1987, 49:729-739
22. Stricklin GP, Welgus HG: Human skin fibroblast collagenase inhibitor. J Biol Chem 1983, 258:12252-12258
23. Herren GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z: Secretion of metalloproteinases by stimulated capillary endothelial cells. J Biol Chem 1986, 261:2814-2818
24. Hunt RC, Fox A, Pakalnis VA, Segel MM, Kosnosky W, Choudhury P, Black EP: Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels. Invest Ophthalmol Vis Sci 1993, 34:3179-3186
25. MacNaul KI, Chartrain N, Lark M, Tocci MJ, Hutchinson NI: Discoordinate expression of Stromelysin, collagenase, and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts. J Biol Chem 1990, 265:17238-17245
26. Lelievre Y, Bouboutou R, Boiziau J, Faucher D, Achard D, Cartwright T: Low molecular weight, sequence based, collagenase inhibitors selectively block the interaction between collagenase and TIMP (tissue inhibitor of metalloproteinases). Matrix 1990, 10:292-299
27. Pelletier J-P, Mineau F, Faure MP, Martel-Pelletier J: Imbalance between the mechanisims of activation and inhibition of metalloproteinases in the early lesions of experimental osteoarthritis. Arthritis Rheum 1990, 33:1466-1476
28. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier J-M, Pelletier P-J: Excess of metalloproteinase over tissue inhibitor of metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis, Lab Invest 1994, 70:807-815
29. Di Girolamo N, McCluskey PJ, Lloyd A, Wakefield D: Stromelysin (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase (TIMP-1) mRNA expression in scleritis. Ocular Immunol Inflamm 1995, 3:181-194
30. Di Girolamo N, Underwood A, McCluskey PJ, Wakefield D: Functional activity of plasma fibronectin in patients with diabetes mellitus. Diabetes 1993, 42:1606-1613
31. Chomzynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
32. Maniatis TE, Fritsch EF, Sambrook J: Molecular cloning: A Laboratory Manual, Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1982
33. Burnette WN: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981, 112:195-203
34. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerised substrates. Anal Biochem 1980, 102:196-202
35. Zucker S, Conner C, DiMassmo BI, Ende H, Drews M, Seiki M, Bahou WF: Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 1995, 270:23730-23738
36. Mackenzie W: Practical Treatise of the Diseases of the Eye. London, Churchill, 1830, p 406
37. Watson PG: The nature and treatment of scleral inflammation, Trans Ophthalmol Soc UK 1982, 102:257-281
38. Young RD, Watson PG: Microscopical studies of necrotising scleritis. II. Collagen degradation in the scierai stroma, Br J Ophthalmol 1984, 68:781-789
39. Zhou H, Bernhard EJ, Fox FE, Billings PC: Induction of metalloproteinase activity in human T lymphocytes, Biochim Biophys Acta 1993, 1177:174-178
40. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL: T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995, 154:4379-4389
41. Eyre DR, Wu J-J: Collagen structure and cartilage matrix integrity. J Rheumatol 1995, 22:82-85
42. Rada JA, Brenza HL: Increased latent gelatinase activity in the sciera of visually deprived chicks. Invest Ophthalmol Vis Sci 1995, 36:1555-1565
43. Aimes RT, Quigley JP: Matrix metalloproteinase-2 is an interstitial collagenase. J Biol Chem 1995, 270:5872-5876
44. Nguyen Q, Mort JS, Roughely PJ: Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest 1992, 89:1189-1197
45. Gress TM, Muller-Pillasch F, Lerch MM, Friess H, Buchler M, Adler G: Expression and in situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer, Int J Cancer 1995, 62:407-413
46. Ogata Y, Enghild JJ, Nagase H: Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992, 267:3581-3584
47. Ahmed AA, Nordlind K, Schultzberg M, Linden S: Interleukin-1α- and β-, interleukin-6- and tumour necrosis factor-α-like immunoreactivities in chronic granulomatous skin conditions. Acta Derm Venereol 1994, 74: 435-440
48. Ruco LP, Stoppacciaro A, Pomponi D, Boraschi D, Santoni A, Tagliabue A, Uccini S, Baroni CD: Immunoreactivity for IL-1β and TNF-α in human lymphoid and nonlymphoid tissues. Am J Pathol 1989, 135:889-897
49. Evans PJ, Eustace P: Scleromalacia perforans associated with Crohn's disease: treatment with sodium versenate (EDTA). Br J Ophthalmol 1973, 57:330-335